V010-1396 Screening compound: N-cyclohexyl-4-(4-{2-[(propan-2-yl)[(propan-2-yl)carbamoyl]amino]acetamido}phenyl)piperazine-1-carboxamide

V010-1396 Screening compound: N-cyclohexyl-4-(4-{2-[(propan-2-yl)[(propan-2-yl)carbamoyl]amino]acetamido}phenyl)piperazine-1-carboxamide
V010-1396 Screening compound: N-cyclohexyl-4-(4-{2-[(propan-2-yl)[(propan-2-yl)carbamoyl]amino]acetamido}phenyl)piperazine-1-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V010-1396
N-cyclohexyl-4-(4-{2-[(propan-2-yl)[(propan-2-yl)carbamoyl]amino]acetamido}phenyl)piperazine-1-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V010-1396

Molecular Formula

C26H42N6O3 (C26 H42 N6 O3)

Compound Name

N-cyclohexyl-4-(4-{2-[(propan-2-yl)[(propan-2-yl)carbamoyl]amino]acetamido}phenyl)piperazine-1-carboxamide

IUPAC name

N-cyclohexyl-4-(4-{2-[(propan-2-yl)[(propan-2-yl)carbamoyl]amino]acetamido}phenyl)piperazine-1-carboxamide

SMILES

CC(C)NC(N(CC(Nc(cc1)ccc1N(CC1)CCN1C(NC1CCCCC1)=O)=O)C(C)C)=O

InChI

InChI=1S/C26H42N6O3/c1-19(2)27-26(35)32(20(3)4)18-24(33)28-22-10-12-23(13-11-22)30-14-16-31(17-15-30)25(34)29-21-8-6-5-7-9-21/h10-13,19-21H,5-9,14-18H2,1-4H3,(H,27,35)(H,28,33)(H,29,34)

InChI Key

RFZCLQCMUVOZRW-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14257354

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

486.66

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

3.00

Rotatable Bond Count

12.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

4.220

Distribution Coefficient, logD

4.198

Water Solubility, LogSw

-4.02

Polar Surface Area

78.508

Acid Dissociation Constant (pKa)

12.61

Base Dissociation Constant (pKb)

6.12

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

65.40

V010-1396 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Lipid Metabolism Library (9174 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cardiovascular
  • Metabolic
  • Hemic and lymphatic
  • Cardiovascular
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds

References: we are preparing a list of scientific research reports with V010-1396 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V010-1396?
Check Price and Availability of V010-1396, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V010-1396 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V010-1396
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V010-1396
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V010-1396 available by request